Company

About

APEPTICO

APEPTICO

Vienna, Austria

APEPTICO is a privately-held biotechnology company based in Austria, developing peptide-based products targeting chronic and life-threatening diseases. The peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. By concentrating on synthetically produced protein structures APEPTICO avoids general risks associated with gene- and cell-technologies. APEPTICO makes use of its technology platforms PEPBASE(TM) and PEPSCREEN(TM) to significantly reduce cost and to shorten time to market.

ThioMatrix

ThioMatrix

Trientlgasse 65, Innsbruck, Tyrol 6020, AT

ThioMatrix is specialised on the development of non-invasive drug delivery systems utilizing its core technologies: the Thiomer Technology and SEDDS Technology. Due to the great potential of these technologies the efficacy of non-invasively delivered: -therapeutic peptides -peptidomimetics -nucleic acids such as oligonucleotides, plasmid DNA and siRNA -class III drugs according to the biopharmaceutical classification system (BCS) -drugs being substrate of efflux pumps such as anticancer drugs can be tremendously improved. A wide network of partnerships and collaborations with hospitals, veterinary institutions, CROs and universities has been established to conduct preclinical through to clinical development of our delivery products. This network coupled to our technologies and expertise gives us the edge to reduce the time to market to develop the optimal delivery systems for your therapeutic candidates. To learn more about our drug delivery technologies, please visit the technology section where you will also find the results of various in vivo studies demonstrating the advantages of our novel drug delivery products.